about
Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?Antifungal Therapy: New Advances in the Understanding and Treatment of MycosisAnti-trichophyton activity of protocatechuates and their synergism with fluconazole.Serological diagnosis of paracoccidioidomycosis: high rate of inter-laboratorial variability among medical mycology reference centersCandida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.Antifungal Activity of Decyl Gallate against Several Species of Pathogenic Fungi.Dynamics and conformational studies of TOAC spin labeled analogues of Ctx(Ile(21))-Ha peptide from Hypsiboas albopunctatus.Intermolecular interactions of the malate synthase of Paracoccidioides sppIn vitro characterization of Trichophyton rubrum and T. mentagrophytes biofilms.An Intracellular Arrangement of Histoplasma capsulatum Yeast-Aggregates Generates Nuclear Damage to the Cultured Murine Alveolar Macrophages.Decreased expression of 14-3-3 in Paracoccidioides brasiliensis confirms its involvement in fungal pathogenesis.New antimicrobial therapies used against fungi present in subgingival sites--a brief review.Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.The multifaceted roles of metabolic enzymes in the Paracoccidioides species complex.Antifungal activity of plant-derived essential oils on Candida tropicalis planktonic and biofilms cells.Virulence of Cryptococcus sp. Biofilms In Vitro and In Vivo using Galleria mellonella as an Alternative ModelInfluence of the Paracoccidioides brasiliensis 14-3-3 and gp43 proteins on the induction of apoptosis in A549 epithelial cells.Early Endosome Antigen 1 (EEA1) decreases in macrophages infected with Paracoccidioides brasiliensis.Adhesion of Histoplasma capsulatum to pneumocytes and biofilm formation on an abiotic surface.Topical nitric oxide releasing nanoparticles are effective in a murine model of dermal Trichophyton rubrum dermatophytosis.Effect of usnic acid on Candida orthopsilosis and C. parapsilosis.Could Histoplasma capsulatum Be Related to Healthcare-Associated Infections?Microplate alamarBlue assay for Paracoccidioides susceptibility testing.Frequency and genetic diversity of the MAT1 locus of Histoplasma capsulatum isolates in Mexico and BrazilAlkyl Protocatechuate-Loaded Nanostructured Lipid Systems as a Treatment Strategy for Paracoccidioides brasiliensis and Paracoccidioides lutzii In VitroAnticandidal efficacy of cinnamon oil against planktonic and biofilm cultures of Candida parapsilosis and Candida orthopsilosis.Altered ex vivo expression of caspase 8, caspase 9, and Bcl-2 is associated with T-cell hyporeactivity in patients with paracoccidioidomycosis.The role of apoptosis in the antigen-specific T cell hyporesponsiveness of paracoccidioidomycosis patients.Cryptococcosis outbreak in psittacine birds in Brazil.Identification of a gene encoding adaptin-like protein in the Paracoccidioides brasiliensis genome by random amplified polymorphic DNA analysis.Highlights in nanocarriers for the treatment against cervical cancer.Genetic relatedness of commensal strains of Candida albicans carried in the oral cavity of patients' dental prosthesis users in Brazil.Applications of Invertebrate Animal Models to Dimorphic Fungal InfectionsPolyserositis in a patient with acute paracoccidioidomycosis and hepatosplenic schistosomiasisParacoccidioidomycosis manifesting as oral lesions: clinical, cytological and serological investigationDifferential antibody isotype expression to the major Paracoccidioides brasiliensis antigen in juvenile and adult form paracoccidioidomycosisImmunosuppression in paracoccidioidomycosis: T cell hyporesponsiveness to two Paracoccidioides brasiliensis glycoproteins that elicit strong humoral immune responseHuman chromosome aberrations induced in vitro by Paracoccidioides brasiliensis glycoproteic component (GP 43)Imbalance of IL-2, IFN-gamma and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosisIL-12 and neutralization of endogenous IL-10 revert the in vitro antigen-specific cellular immunosuppression of paracoccidioidomycosis patients
P50
Q26740363-55C75DA6-820A-493C-A34E-E9CC9C2A0808Q28818603-5D6A261C-14B0-4FC4-902B-5A4F82FC38D8Q33862427-D3E442C8-2B54-4748-A3AE-80C464879550Q34165789-5FF195DB-3706-49CD-ADDB-4E15D6DC7896Q34313668-53C6B5CA-B1BD-46E9-9543-9A55F6FC5793Q34645936-86C19F21-9056-45A0-B414-FF5B44394160Q34667839-484D2D34-12F1-4A28-8452-F28BB0E09089Q34721915-D23A0E22-17A3-4B88-AD79-9534C281558FQ35173071-38F3CDC5-5CAC-4D96-A883-D0C8EF76426FQ36448573-FC8BC769-1B9D-4A70-ABFE-672A7F4DEE87Q37197338-79AD951A-E104-4464-B2CF-866F8E8FFB16Q37890081-7493EEF6-DC6D-4A7E-AE46-3D60A4637296Q38154164-91AF64C0-8107-4687-9E7C-FA1A587A6053Q38310218-6A4C296E-9C08-4CD4-919B-82E941B22198Q38794883-6554FC62-1B9C-4F4F-96B7-F3103645487EQ38858709-62F57BA3-FB17-43D0-A788-504630B39DAFQ38868031-D0D4E809-9D1C-4278-8BC5-BCB84240AD11Q39169557-7B4B21B2-81F0-4D53-81A8-91073A8B12C6Q39316488-347DF77A-927A-488A-AE43-0F96B8D25B11Q40132989-915E95E6-408E-49C2-BB05-E611ECD458E6Q40325883-3674C203-8445-4C2F-9619-32AD0E354182Q41142605-35FBB0F1-9C1C-496B-BF6F-A5F45599AFA7Q41158301-7A231478-D2C4-4854-9D48-A7C9E545D351Q41437871-4B2529E9-A72E-4863-ACE0-62371AAD2F13Q41940101-41554C13-8D0F-4698-A5B5-2F422EC05A1BQ42730616-C7259B79-0086-491D-81ED-75E8EFA48C4AQ43117837-24F1CFE2-43F0-4DEB-86C0-9722A9938E39Q44249212-262F2025-32EC-4D32-9EFC-14B72843C577Q45097434-45FDB5F0-7F3F-45A7-B403-B3B0EA126FBDQ48078735-231DDB1E-6F50-4BD4-8685-A7EFA73B088BQ50230994-970A0844-31C3-4B94-BD05-24D7C5FD4D20Q50900069-DD03C526-E4DF-4ACF-AB68-E8DE375530ACQ57810558-42CB5650-57FF-4981-9C81-7CBA64B13EA4Q71759180-3251AE89-96FE-4671-B336-12C9CA03DEEAQ72377845-EA16FC87-43C5-42EE-862E-9C522CAAE382Q73284051-2874865E-2A47-4407-8894-3C9D0ECB53ECQ73292684-2AE493A0-C5C6-4472-B983-2B062484CD0BQ73338575-3012615D-F690-466F-8902-0386F7EA3B07Q73584683-B2DC1FA1-E3F2-4EAF-AC5D-C8F9277CD785Q74484075-F2456202-30B7-4E7F-AE13-CA0039A79F46
P50
description
researcher
@en
wetenschapper
@nl
name
M J Mendes-Giannini
@en
M J Mendes-Giannini
@nl
type
label
M J Mendes-Giannini
@en
M J Mendes-Giannini
@nl
prefLabel
M J Mendes-Giannini
@en
M J Mendes-Giannini
@nl
P106
P31
P496
0000-0002-8059-0826